Investigation announced for Long-Term Investors in shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR)

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Voyager Therapeutics, Inc.

Investors who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) and currently hold any of those NASDAQ: VYGR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Voyager Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.

Cambridge, MA based Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. Voyager Therapeutics, Inc. reported that its annual Total Revenue rose from $7.61 million in 2018 to $104.39 million in 2019, and that its normalized Loss declined from $88.28 million in 2018 to $43.59 million in 2019.

On October 12, 2020, Voyager Therapeutics, Inc. disclosed that it "has received feedback from the U.S. Food and Drug Administration (FDA) on the Investigational New Drug (IND) submission for VY-HTT01 for the treatment of Huntington's disease." Specifically, Voyager advised investors that it "has been notified that the IND was placed on clinical hold pending the resolution of certain chemistry, manufacturing and controls (CMC) matters."

Shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) declined on October 13, 2020 to $10.90 per share.

Those who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.